A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer

[1]  H. Ueno,et al.  A multicenter phase II study of gemcitabine and S-1 combination therapy (GS therapy) in patients with metastatic pancreatic cancer , 2007 .

[2]  B. Chauffert,et al.  Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  A. Benson,et al.  A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201 , 2008 .

[4]  E. Touboul,et al.  Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en Oncologie phase II study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Berlin,et al.  Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  W. Ajiki,et al.  Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. , 2006, Japanese journal of clinical oncology.

[7]  J. Furuse,et al.  A late phase II study of S-1 for metastatic pancreatic cancer , 2008, Cancer Chemotherapy and Pharmacology.

[8]  D. Goldstein,et al.  Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer , 2007, British Journal of Cancer.

[9]  Douglas B. Evans,et al.  Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy , 2007, Cancer.

[10]  Edgar Ben-Josef,et al.  Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. , 2007, International journal of radiation oncology, biology, physics.

[11]  J. Quivey,et al.  A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. , 2007, International journal of radiation oncology, biology, physics.

[12]  A. Ohtsu,et al.  Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912) , 2007 .

[13]  H. Narahara,et al.  Randomized phase III study of S-1 alone versus S-1 + cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) SPIRITS: S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer , 2007 .

[14]  E. Touboul,et al.  Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Winston,et al.  Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma? , 2004, Journal of Gastrointestinal Surgery.

[16]  J. Furuse,et al.  A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancer. , 2004, Hepato-gastroenterology.

[17]  N. Boku.  Randomized Phase III study of 5-fluorouracil alone versus combination of irinotecan and cisplatin versus S-1 alone in advanced gastric cancer (JCOG9912) , 2007 .

[18]  E. Kaya,et al.  Phase II Study of Induction Chemotherapy with Gemcitabine plus 5-Fluorouracil Followed by Gemcitabine-Based Concurrent Chemoradiotherapy for Unresectable Locally Advanced Pancreatic Cancer , 2006, Tumori.

[19]  H. Einsele,et al.  Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  T. Ishihara,et al.  Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer , 2006, British Journal of Cancer.

[21]  H. Ueno,et al.  A Phase I Study of Combination Chemotherapy with Gemcitabine and Oral S-1 for Advanced Pancreatic Cancer , 2005, Oncology.

[22]  L. Case,et al.  Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer , 2005, American journal of clinical oncology.

[23]  R. Labianca,et al.  Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  L. Traverso,et al.  Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by Computed Tomography , 2005, Surgical Endoscopy And Other Interventional Techniques.

[25]  H. Ueno,et al.  A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer , 2002, British Journal of Cancer.

[26]  R. Wolff,et al.  Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  C. F. Fernandez-del Castillo,et al.  Laparoscopy and peritoneal cytology in the staging of pancreatic cancer. , 2000, Journal of hepato-biliary-pancreatic surgery.

[28]  J. Tepper,et al.  Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  J. Barkin,et al.  Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group , 1981, Cancer.

[30]  H. Keen,et al.  ORAL HYPOGLYCÆMICS IN DIABETES MELLITUS , 1975, The Lancet.

[31]  C. Moertel,et al.  Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. , 1969, Lancet.